MDMA for PTSD? How ecstasy ingredient works in the brain The active ingredient in the drug ecstasy is set to be studied in large-scale clinical trials as a treatment for people with post-traumatic stress disorder, the New York Times reported on Nov. 29.
Most people want to learn about their skin biopsy results online Most people want to learn about their skin biopsy results over the internet - especially when they're benign, according to new research.
Woman battling breast cancer stunned after stranger helps pay for her family meal Talk about the kindness of strangers.
More than half of older Americans skip dental checkups Only about one in nine U.S. adults with Medicare coverage have dental insurance, and many of them may be putting off oral healthcare as a result, a recent study suggests.
Heart problems tied to increased risk of suicide People with acute coronary syndrome caused by poor blood flow to the heart may be at an increased risk of suicide - especially in the six months following their diagnosis, according to a new study from Taiwan.
Brain activity may help predict fall risk in older adults People whose brains work the hardest when they try to walk and talk at the same time may have a higher risk of falling in the future than seniors who can do both with ease, a new study suggests.
Texas eyes immunizations as more kids file exemptions Texas could be the epicenter for the nation's next major fight over stricter requirements for immunizations as rates of schoolchildren who refuse shots for non-medical reasons climb in America's second-largest state.
Doctor under fire for letter allegedly asking patients to fund retirement A Canadian doctor who allegedly sent a letter to patients asking them to sponsor his retirement has come under fire from regulators.
Pittsburgh parents charged after 2-month-old allegedly overdoses on methadone A Pittsburgh man and woman are facing charges after their 2-month-old baby was allegedly revived by the rescue drug Narcan and tested positive for methadone.
GNC enters non-prosecution agreement over sales of illegal supplements GNC Holdings Inc, the largest global dietary supplement retailer, has agreed to pay $2.25 million and reform its practices in a pact to avoid federal prosecution over its alleged sale of illegal dietary supplements, the U.S. Department of Justice said on Wednesday.
